Courtagen Life Sciences, Inc. - Product Pipeline Analysis

1
Courtagen Life Sciences, Inc. - Product Pipeline
AnalysisMarket Research Reports Distributor
- Aarkstore.com have vast database on market
research reports, company financials, company
profiles, SWOT analysis, company report, company
statistics, strategy review, industry report,
industry research to provide excellent and
innovative service to our report
buyers.Aarkstore.com have very interactive
search feature to browse across more than
2,50,000 business industry reports. We are built
on the premise that reading is valuable, capable
of stirring emotions and firing the imagination.
Whether you're looking for new market research
report product trends or competitive industry
analysis of a new or existing market,
Aarkstore.com has the best resource offerings and
the expertise to make sure you get the right
product every time.
2
Courtagen Life Sciences, Inc. - Product Pipeline
Analysis

• SummaryCourtagen Life Sciences, Inc.
  (Courtagen), formerly known as Avantra
  Biosciences Corporation, is a life science
  company. It focuses on offering genomic and
  proteomic products and services for the treatment
  of neurological and metabolic disorders. The
  companys product portfolio consists of POC
  protein biomarker technologies, namely, Avantra
  Q400 biomarker workstation and QPDx biochip.
  These products allow scientists and clinicians to
  conduct multiplex biomarker analysis for research
  use only from their lab bench or clinical trial
  site. Courtagens service portfolio comprises
  genetic testing services that include, mtSEEK, a
  whole mitochondrial genome analysis nucSEEK, a
  comprehensive sequence analysis of nuclear
  mitochondrial exome, epiSEEK, a comprehensive
  next-generation sequencing analysis for epileptic
  disorders and protein immunoassay tests. The
  company offers these services using proprietary
  testing technologies, namely, Next Gen
  sequencing, Ziphyr bioinformatics, HetAssure and
  VariAssure. The company provides its products and
  services to physicians and the life sciences
  industry. Courtagen is headquartered in Woburn,
  Massachusetts, the US.This report is a source
  for data, analysis and actionable intelligence on
  the Courtagen Life Sciences, Inc. portfolio of
  pipeline products. The report provides detailed
  analysis on each pipeline product with
  information on the indication, the development
  stage, trial phase, product milestones, pipeline
  territory, estimated approval date, and estimated
  launch dateEach pipeline product is profiled to
  cover information on product description,
  function, technology, indication, and
  application. The report is also supplemented with
  a detailed company profile and information on
  clinical trials, wherever applicable.This
  report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  GlobalDatas team of industry experts.

3

• Scope- Detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments.- Detailed
  coverage on all the pipeline products, by
  equipment type, by therapy area, by development
  stage, and by trial phase.- Information on
  product milestones and pipeline territory for
  each product, the estimated approval date, and
  estimated launch date.- Profile of each pipeline
  product with additional information on product
  description, function, technology, indication(s),
  and application.- Data on relevant clinical
  trials and product patent details, wherever
  applicable.- Information on clinical trial,
  wherever applicable, is supplemented with
  information on trial phase, trial status, trial
  objective, trial design, target patients, unique
  physician identifier, primary point, secondary
  point, acronym, participants inclusion,
  participants exclusion, interventions, trial
  results, trial start date, trial end date, study
  type, trial site, trial funding, age eligibility,
  and gender eligibility.
• Reasons to Buy- Develop business strategies by
  understanding the trends and developments driving
  the medical devices pipeline and technology
  landscape globally.- Design and develop your
  product development, marketing and sales
  strategies.- Exploit MA opportunities by
  identifying market players with the most
  innovative pipeline.- Develop market-entry and
  market expansion strategies.- Exploit
  in-licensing and out-licensing opportunities by
  identifying products, most likely to ensure a
  robust return.- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage.- Develop competition strategies by
  identifying the status and likely launch of your
  competitors pipeline products through review of
  the clinical trials, stage and phase of
  development, etc.- Which are the next high-value
  products that your competitor would add in its
  portfolio? identify, understand and capitalize.

4

• List of Tables 4List of Figures 5Key Facts
  6Courtagen Life Sciences, Inc. - Major Products
  and Services 7Courtagen Life Sciences, Inc.
  Pipeline Products by Equipment Type 8Courtagen
  Life Sciences, Inc. Pipeline Products by
  Development Stage 10Courtagen Life Sciences,
  Inc. Pipeline Products by Therapy Area
  12Courtagen Life Sciences, Inc. Pipeline
  Products by Milestone Summary 14Avantra Q400
  Biomarker Workstation 16Avantra Q400 Biomarker
  Workstation Product Status 16Avantra Q400
  Biomarker Workstation Product Description
  16Avantra Q400 Biomarker Workstation Product
  Milestone 16Breast Cancer Diagnostic Panel
  17Breast Cancer Diagnostic Panel Product Status
  17Breast Cancer Diagnostic Panel Product
  Description 17Breast Cancer Diagnostic Panel
  Product Patent Details 17Colorectal Cancer
  Diagnostic Panel 19Colorectal Cancer Diagnostic
  Panel Product Status 19Colorectal Cancer
  Diagnostic Panel Product Description
  19Colorectal Cancer Diagnostic Panel Product
  Patent Details 19Diagnostic Assay - GI Acute
  Radiation Syndrome 21Diagnostic Assay - GI Acute
  Radiation Syndrome Product Status 21Diagnostic
  Assay - GI Acute Radiation Syndrome Product
  Description 21Lung Cancer Diagnostic Panel
  22Lung Cancer Diagnostic Panel Product Status
  22Lung Cancer Diagnostic Panel Product
  Description 22Lung Cancer Diagnostic Panel
  Product Patent Details 22Next Generation
  Biothreat Assay 24Next Generation Biothreat
  Assay Product Status 24Next Generation Biothreat
  Assay Product Description 24Ovarian Cancer
  Diagnostic Panel 25Ovarian Cancer Diagnostic
  Panel Product Status 25Ovarian Cancer Diagnostic
  Panel Product Description 25Ovarian Cancer
  Diagnostic Panel Product Patent Details
  25Pancreatic Cancer Diagnostic Panel
  27Pancreatic Cancer Diagnostic Panel Product
  Status 27Pancreatic Cancer Diagnostic Panel
  Product Description 27Pancreatic Cancer
  Diagnostic Panel Product Patent Details
  27Prostate Cancer Diagnostic Panel 29

5

• Ovarian Cancer Diagnostic Panel Product
  Status 25Ovarian Cancer Diagnostic Panel Product
  Description 25Ovarian Cancer Diagnostic Panel
  Product Patent Details 25Pancreatic Cancer
  Diagnostic Panel 27Pancreatic Cancer Diagnostic
  Panel Product Status 27Pancreatic Cancer
  Diagnostic Panel Product Description
  27Pancreatic Cancer Diagnostic Panel Product
  Patent Details 27Prostate Cancer Diagnostic
  Panel 29Prostate Cancer Diagnostic Panel Product
  Status 29Prostate Cancer Diagnostic Panel
  Product Description 29Prostate Cancer Diagnostic
  Panel Product Patent Details 29QPDx BioChip CRP
  Assay 31QPDx BioChip CRP Assay Product Status
  31QPDx BioChip CRP Assay Product Description
  31QPDx BioChip CRP Assay Product Milestone
  31Sepsis Diagnostic Panel 33Sepsis Diagnostic
  Panel Product Status 33Sepsis Diagnostic Panel
  Product Description 33Sepsis Diagnostic Panel
  Product Patent Details 33Courtagen Life
  Sciences, Inc. - Key Competitors 35Courtagen
  Life Sciences, Inc. - Key Employees 36Courtagen
  Life Sciences, Inc. - Locations And Subsidiaries
  37Head Office 37Recent Developments
  38Courtagen Life Sciences, Inc., Recent
  Developments 38Jun 14, 2011 Avantra Biosciences
  Announces Significant Reduction In Multiplex
  Immunoassay Processing Time 38Jun 06, 2011
  Avantra Biosciences Launches Rapid Assay
  Prototyping Service 38Mar 22, 2011 Avantra
  Biosciences Offers Its Path Slides For Sale
  38Appendix 39Methodology 39About GlobalData
  39Contact Us 39Disclaimer 39

6
List of Tables Courtagen Life Sciences, Inc.,
Key Facts 1Courtagen Life Sciences, Inc. Key
Pipeline Products by Equipment Type 1Courtagen
Life Sciences, Inc. Key Pipeline Products by
Therapy Area 1Courtagen Life Sciences, Inc. Key
Pipeline Products by Development Stage
1Courtagen Life Sciences, Inc., Key Facts
6Courtagen Life Sciences, Inc., Major Products
and Services 7Courtagen Life Sciences, Inc.
Number of Pipeline Products by Equipment Type
8Courtagen Life Sciences, Inc. Pipeline Products
by Equipment Type 9Courtagen Life Sciences, Inc.
Number of Pipeline Products by Development Stage
10Courtagen Life Sciences, Inc. Pipeline
Products by Development Stage 11Courtagen Life
Sciences, Inc. Number of Pipeline Products by
Therapy Area 12Courtagen Life Sciences, Inc.
Pipeline Products by Therapy Area 13Courtagen
Life Sciences, Inc. Number of Pipeline Products
By Milestone Summary 14Courtagen Life Sciences,
Inc. Pipeline Products by Milestone Summary
15Avantra Q400 Biomarker Workstation - Product
Status 16Avantra Q400 Biomarker Workstation -
Product Description 16Avantra Q400 Biomarker
Workstation - Product Milestone 16Breast Cancer
Diagnostic Panel - Product Status 17Breast
Cancer Diagnostic Panel - Product Description
17Breast Cancer Diagnostic Panel - Patent
Details1 17Colorectal Cancer Diagnostic Panel -
Product Status 19Colorectal Cancer Diagnostic
Panel - Product Description 19Colorectal Cancer
Diagnostic Panel - Patent Details1 19Diagnostic
Assay - GI Acute Radiation Syndrome - Product
Status 21Diagnostic Assay - GI Acute Radiation
Syndrome - Product Description 21Lung Cancer
Diagnostic Panel - Product Status 22Lung Cancer
Diagnostic Panel - Product Description 22Lung
Cancer Diagnostic Panel - Patent Details1 22Next
Generation Biothreat Assay - Product Status
24Next Generation Biothreat Assay - Product
Description 24Ovarian Cancer Diagnostic Panel -
Product Status 25Ovarian Cancer Diagnostic Panel
- Product Description 25Ovarian Cancer
Diagnostic Panel - Patent Details1 25Pancreatic
Cancer Diagnostic Panel - Product Status
27Pancreatic Cancer Diagnostic Panel - Product
Description 27
7
Pancreatic Cancer Diagnostic Panel - Patent
Details1 27Prostate Cancer Diagnostic Panel -
Product Status 29Prostate Cancer Diagnostic
Panel - Product Description 29Prostate Cancer
Diagnostic Panel - Patent Details1 29QPDx
BioChip CRP Assay - Product Status 31QPDx
BioChip CRP Assay - Product Description 31QPDx
BioChip CRP Assay - Product Milestone 31Sepsis
Diagnostic Panel - Product Status 33Sepsis
Diagnostic Panel - Product Description 33Sepsis
Diagnostic Panel - Patent Details1 33Courtagen
Life Sciences, Inc., Key Employees 36 List of
Figures Courtagen Life Sciences, Inc. Key
Pipeline Products by Equipment Type 1Courtagen
Life Sciences, Inc. Pipeline Products by
Equipment Type 8Courtagen Life Sciences, Inc.
Pipeline Products by Development Stage
10Courtagen Life Sciences, Inc. Pipeline
Products by Therapy Area 12Courtagen Life
Sciences, Inc. Pipeline Products by Milestone
Summary 14 
8

• For more information, please visit
• http//www.aarkstore.com/reports/Courtagen-Life-Sc
  iences-Inc-Product-Pipeline-Analysis-240132.html
• Or email us at contact_at_aarkstore.com or call
  919272852585
• http//www.aarkstore.com/search/viewresults.asp?se
  archProduct20Pipeline20AnalysisPubId
• pagenum1
• Related Reports
• 2013 French Hospital Hematology and Flow
  Cytometry Market
• United Arab Emirates In Vitro Diagnostics
  Investment Opportunities, Analysis and Forecasts
  to 2018
• Chile In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Norway In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Aleva Neurotherapeutics SA - Product Pipeline
  Analysis.
• DiaPat GmbH - Product Pipeline Analysis.
• Manhattan Scientifics, Inc. (MHTX) - Product
  Pipeline Analysis.
• MicroTransponder Inc. - Product Pipeline
  Analysis.

9

• Contact Us
• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise